Koyfin Home > Directory > Health Care > Oxford Immunotec > Long-Term Debt

Oxford Immunotec Long-Term Debt Chart (OXFD)

Oxford Immunotec annual/quarterly Long-Term Debt from 2012 to 2020.
  • Oxford Immunotec Long-Term Debt for the quarter ending September 09, 2020 was $0m a 87.20% increase of 0m year over year
  • Oxford Immunotec Long-Term Debt for the last 12 months ending September 09, 2020 was $0m a 87.20% increase of 0m year over year
  • Oxford Immunotec Annual Long-Term Debt for 2019 was $0m a -231.25% decrease of 0m from 2018
  • Oxford Immunotec Annual Long-Term Debt for 2018 was $0m a -28,066.04% decrease of -30m from 2017
  • Oxford Immunotec Annual Long-Term Debt for 2017 was $30m a 0.85% increase of 0m from 2016
Other Cash Flow Metrics:
  • Oxford Immunotec Cash Flow from Operations for the quarter ending June 06, 2018 was $-7m a 0.60% decrease of 0m year over year
  • Oxford Immunotec Levered Free Cash Flow (FCF) for the quarter ending June 06, 2018 was $-7m a -0.81% increase of 0m year over year
  • Oxford Immunotec Total Revenue for the quarter ending September 09, 2018 was $16m a -55.93% decrease of -9m year over year
View Chart On Koyfin

Quarterly OXFD Long-Term Debt Data

09/2020$0m
06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$30m

Annual OXFD Long-Term Debt Data

2019$0m
2018$0m
2017$30m
2016$30m
2015$0m
2014$0m
2013$1m
2012$0m
2011$0m